𝔖 Bobbio Scriptorium

✦ LIBER ✦

O140 Micafungin versus caspofungin in patients with invasive candidiasis or candidaemia: a Phase III, randomised, double-blind, parallel group, non-inferiority study

✍ Scribed by B. Dupont; J. De Waele; R. Betts; C. Rotstein; M. Nucci; L. Arnold; L. Kovanda; C. Wu; D. Buell

Book ID: 119564233
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 50 KB
Volume: 29
Category: Article
ISSN: 0924-8579
DOI: 10.1016/s0924-8579(07)70090-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rationale and Design of MARQUEE: A Phase

Rationale and Design of MARQUEE: A Phase III, Randomized, Double-Blind Study of Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib in Previously Treated Patients With Locally Advanced or Metastatic, Nonsquamous, Non–Small-Cell Lung Cancer

✍ Giorgio V. Scagliotti; Silvia Novello; Joan H. Schiller; Vera Hirsh; Lecia V. Se 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 332 KB

Treatment Rationale Study Design for the

Treatment Rationale Study Design for the MetLung Trial: A Randomized, Double-Blind Phase III Study of Onartuzumab (MetMAb) in Combination With Erlotinib Versus Erlotinib Alone in Patients Who Have Received Standard Chemotherapy for Stage IIIB or IV Met-Positive Non–Small-Cell Lung Cancer

✍ David R. Spigel; Martin J. Edelman; Tony Mok; Kenneth O'Byrne; Luis Paz-Ares; We 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 255 KB